Current grants
Building a better future for allWe tackle real-world problems and commit to building a better future for all in conjunction with our partners!
Indeed, as a reference research center in the life sciences sector, we continuously lead, or take part in, exciting applied-research projects aimed at developing innovative technologies, products or services with regional and international partners.
Below is a list of current grants in which the CER Groupe is a participant:
- Optymevax - Win4DOC : 27/06/2022 - 27/06/2026
In silico design and development of optimized versions of key enzymes involved in the production of RNA vaccines
- NEMO - BioWIN : 01/10/2023 - 30/09/2025
New-Biological-Entity End-to-end Modeling and Optimization
- CoZyme - COST : 01/01/2023 - 31/12/2026
Establishing a Pan-European Network on Computational Redesign of Enzymes
- Multichip - Eurostars : 01/05/2023 - 30/04/2026
Rapid automated multiplex laboratory diagnostics for autoimmune diseases
- Safety Assessment of Novel Foods and Nutrient Sources - Framework Partn. Agreem. : 01/01/2023 - 31/12/2026
Support to EFSA in the Safety Assessment of Novel Foods and Nutrient Sources
- FoodWal /Peptiboost - Win4Excellence : 01/01/2023 - 31/12/2026
Bioactive peptides formulated as protein hydrolysates applicable in human and animal health
- Wal-bioimaging - FEDER : 01/07/2023 - 31/12/2025
Creation of a coordinated network of imaging technology platforms involving universities and accredited research centres.
- PEPVac - FEDER : 01/07/2023 - 31/12/2025
Setting up an innovative platform for the preclinical evaluation of new vaccine candidates and risk factors, based on a strengthened partnership between universities and accredited research centres.
- WalProt - FEDER : 01/09/2023 - 31/12/2025
Development of new avenues for valorizing plant and alternative proteins for the human food sector
- Ensured - SPF : 01/09/2023 - 01/01/2026
New open strategy for impurity surveillance of commercial microbial fermentation food products: Food supplements and vitamins as proof of concept
- Phenix - FEDER : 01/011/2023 - 30/10/2025
Plateformes technologiques et analytiques d’excellence wallonne en agro-alimentaire
- Passport - Win4Collective : 01/12/2023 - 31/12/2025
Plasma surface modification of functional implants for more effective tissue regeneration
- Phenix /GosBooster - FEDER : 01/11/2023 - 31/12/2025
Improvement of muco-adhesive properties of probiotics
- Phenix / NglycBooster - FEDER : 01/11/2023 - 31/12/2025
Development of new HMO-like preparations
- Phenix / FosBooster - FEDER : 01/11/2023 - 31/12/2025
Fine molecular characterisation of prebiotics
- MicroMIC - Win4Collective : 01/01/2024 - 31/12/2025
Microfluidics for Metabolomics
- SOLIT - Competitivity Pole : 01/01/2024 - 31/12/2026
Development of an innovative platform for highly specific tumor suppressive agents delivered by an allogenic cell-derived platform
- Hybrid-TX - Competitivity Pole : 01/01/2024 - 31/12/2026
Development of a hybrid approach comprising a viral vector and an mRNA vector for the development of a personalised cancer treatment solution
The project aims to develop innovative solutions to combat antibioresistance